
Auteur S. DOBRER
|
Documents disponibles écrits par cet auteur (3)

S. YOUNG ; E. WOOD ; M. J. MILLOY ; K. DEBECK ; S. DOBRER ; E. NOSOVA ; T. KERR ; K. HAYASHI | 2018
Dans Substance Abuse (Vol.39, n°4, 2018) Article : PériodiqueBackground: People who inject drugs (PWID) have high rates of hepatitis C virus (HCV) infection. Little is known about the rates of diagnosis and treatment for HCV among PWID. Therefore, this study aims to characterize the cascade of care in Van[...]Nouveauté
A. MAH ; M. W. HULL ; K. DEBECK ; M. J. MILLOY ; S. DOBRER ; E. NOSOVA ; E. WOOD ; T. KERR ; K. HAYASHI | 2017
Dans International Journal of Drug Policy (Vol.47, September 2017) Article : PériodiqueBackground: Knowledge of hepatitis C virus (HCV) is believed to be important in altering risk behaviour, improving engagement in care, and promoting willingness to initiate HCV treatment. We assessed factors associated with HCV knowledge and tre[...]Nouveauté
K. DEBECK ; E. WOOD ; H. DONG ; S. DOBRER ; K. HAYASHI ; J. MONTANER ; T. KERR | 2016
Dans International Journal of Drug Policy (Vol.34, August 2016) Article : PériodiqueThe rapid increase of non-medical prescription opioid (PO) use among youth has been described as the most alarming drug use trend in North America (Compton and Volkow, 2006, McCabe et al., 2008 and Okie, 2010). After cannabis, youth consistently[...]